In addition, accumulating evidence from both preclinical and clinical studies suggests that AIs may modulate the immune infiltrate composition in the context of BC TME by hindering naïve T-cell differentiation into T-regulatory cells (FOXP3+ T cells), resulting in a more favorable CD8+/FOXP3+ ratio [156,157]. Here, CD8A is linked to breast cancer.